Cancer Precision Diagnosis Firm 3D Medicines Raises RMB280M
January 6, 2020 — 09:47 CST
This Data Is Locked!
This area is available only to Subscribers.
A Chinese cancer precision diagnostics firm 3D Medicines recently completed a 280 million yuan (US$40 million) financing for its diagnostic business segment. This round of... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals